POOLED SAFETY RESULTS OVER 24 WEEKS FROM THE ENHANCE PROGRAM WITH ENSIFENTRINE, A NOVEL DUAL PHOSPHODIESTERASE (PDE) 3 AND 4 INHIBITOR
CHEST Journal（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined